Stock Price Quote

IOL CHEMICALS AND PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE421.951.05 (+0.25 %)
PREV CLOSE ( ) 420.90
OPEN PRICE ( ) 423.90
BID PRICE (QTY) 421.60 (23)
OFFER PRICE (QTY) 421.95 (7)
VOLUME 22403
TODAY'S LOW / HIGH ( )420.05 423.95
52 WK LOW / HIGH ( )333 535.6
NSE422.501.7 (+0.4 %)
PREV CLOSE( ) 420.80
OPEN PRICE ( ) 421.00
BID PRICE (QTY) 422.00 (6)
OFFER PRICE (QTY) 422.20 (30)
VOLUME 62455
TODAY'S LOW / HIGH( ) 420.35 424.20
52 WK LOW / HIGH ( )330.85 535.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1986
Management Info
Rajender Mohan Malla - Chairman Varinder Gupta - Managing Director
Registered Office

Address Village Fatehgarh Channa,Mansa Road, ,
Barnala,
Punjab-148101

Phone 01679-285285-86

Email investor@iolcp.com

Website www.iolcp.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE, MCX

NEWS

02Jul IOL Chemicals gets nod to export ‘Feno
IOL Chemicals and Pharmaceuticals has received approval from China’s Dru..
02Jul IOL Chemicals zooms on getting nod to
IOL Chemicals is currently trading at Rs. 433.95, up by 24.65 points or..
18Jun Iol Chemicals & Pharmaceuticals inform
Iol Chemicals & Pharmaceuticals has informed that it enclosed copy o..
15Jun IOL Chemicals & Pharmaceuticals inform
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
12Jun IOL Chemicals gets CEP certificate for
IOL Chemicals and Pharmaceuticals has received Certificate of Suitabilit..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit281.91354.2
Gross Profit 377.7 1826.4
Operating Profit 5762615.9
Net Sales 5039.221327.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  8510.10 (2.46%)
M.Cap ( in Cr)10916.95
RPG Life Sciences (BSE)
peergroup  1717.60 (4.70%)
M.Cap ( in Cr)2821.72
Alembic Pharma (BSE)
peergroup  1054.15 (7.29%)
M.Cap ( in Cr)20271.55
Astrazeneca Pharma I (BSE)
peergroup  6690.75 (0.99%)
M.Cap ( in Cr)16785.00
Pfizer (BSE)
peergroup  5007.00 (1.31%)
M.Cap ( in Cr)22942.26

Shareholding Pattern

NON-INSTITUTION 50.11%
PROMOTERS 48.19%
MUTUAL FUNDS/UTI 0.08%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About IOL Chemicals And Pharmaceuticals Ltd.

IOL Chemicals And Pharmaceuticals Ltd. was incorporated in the year 1986. Its today's share price is 421.95. Its current market capitalisation stands at Rs 2477.37 Cr. In the latest quarter, company has reported Gross Sales of Rs. 22171.1 Cr and Total Income of Rs.22426.8 Cr. The company's management includes Abhay Raj Singh, Sharad Tyagi, Kushal Kumar Rana, Harpal Singh, Sandhya Mehta, Abhiraj Gupta, Vikas Gupta, Varinder Gupta, Rajender Mohan Malla.

It is listed on the BSE with a BSE Code of 524164 , NSE with an NSE Symbol of IOLCP and ISIN of INE485C01011. It's Registered office is at Village Fatehgarh Channa,Mansa Road, Barnala-148101, Punjab. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Ashwani & Associates, SC Vasudeva & Co, SCV & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.